5 amino 1mq with semaglutide 5-Amino-1MQ 5-Amino-1MQ (50mg) - DNA Peptide
Description
Some researchers and hair loss communities view AHK-Cu as a more hair-targeted analogue of GHK-Cu, owing to its proposed follicular activity and the body of in vitro work exploring its effects on follicle keratinocytes

Regulatory note: The FDA added injectable GHK-Cu to a high-risk compounded substance list in September 2023

Allergies and Sensitivities: Some individuals may be allergic or sensitive to specific peptides or ingredients in peptide formulations
The 50mg formulation provides researchers with sufficient material for investigating 5-Amino-1MQ effects on cellular metabolism, NAD+ levels, and metabolic parameters in controlled laboratory settings

The comparison reveals important differences that might make GHK-Cu the better choice for some users
